People · Operator

Michael E. Grey

Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals

1
Companies
1
Filings
$50.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Achillion Pharmaceuticals IncPharmaceuticalsSeries C$50.1M$1.8B2010
Operator network

Michael E. Grey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David I Scheer · 4 companies · 1 sharedDavid I ScheerRobert L. Van Nostrand · 4 companies · 1 sharedRobert L. Van Nos…David P. Wright · 2 companies · 1 sharedDavid P. WrightGary E. Frashier · 2 companies · 1 sharedGary E. FrashierMichael D. Kishbauch · 2 companies · 1 sharedMichael D. Kishba…Nicholas J. Simon · 2 companies · 1 sharedNicholas J. SimonDennis C. Liotta · 1 companies · 1 sharedDennis C. LiottaElizabeth S. Olek · 1 companies · 1 sharedElizabeth S. OlekGautam S. Shah · 1 companies · 1 sharedGautam S. ShahJason S. Fisherman · 1 companies · 1 sharedJason S. FishermanJoseph S. Truitt · 1 companies · 1 sharedJoseph S. TruittMary Kay S. Fenton · 1 companies · 1 sharedMary Kay S. FentonMilind S. Deshpande · 1 companies · 1 sharedMilind S. Deshpan…Achillion Pharmaceuticals Inc · $50.1M raisedAchillion Pharmaceuti…Michael E. GreyMG
Michael E. Grey Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Michael E. Grey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David I Scheer14
Robert L. Van Nostrand14
Michael D. Kishbauch12
Nicholas J. Simon12
David P. Wright12
Gary E. Frashier12
Gautam S. Shah11
Joseph S. Truitt11
Elizabeth S. Olek11
Mary Kay S. Fenton11
Milind S. Deshpande11
Dennis C. Liotta11
Jason S. Fisherman11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.